Arecor Therapeutics (AREC) Share Price, News & Analysis

Company Overview

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. It has a research collaboration with TRx Biosciences Limited for the formulation development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist product. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Key Stats

• Today's Range: 75 to 79.50
• 50-Day Range: 63.39 to 79
• 52-Week Range: 62.55 to 199
• Volume: 16,729 shs
• Average Volume: 14,367 shs
• Market Capitalization: £28.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AREC Stock Analysis - Frequently Asked Questions

How have AREC shares performed this year?

Arecor Therapeutics' stock was trading at GBX 182.50 on January 1st, 2024. Since then, AREC stock has decreased by 58.1% and is now trading at GBX 76.50.
View the best growth stocks for 2024 here.

How do I buy shares of Arecor Therapeutics?

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Arecor Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Coal
• Current Symbol: LON:AREC
• CUSIP: N/A
• CIK: N/A
• Web: www.americanresourcescorp.com
• Phone: 44 1223 426 060
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.28)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-8,670,000.00
• Net Margins: -176.89%
• Pretax Margin: N/A
• Return on Equity: -94.76%
• Return on Assets: -37.31%

Debt

• Debt-to-Equity Ratio: 5.51
• Current Ratio: 1.37
• Quick Ratio: 6.24

Sales & Book Value

• Annual Sales: £4.90 million
• Price / Sales: 5.90
• Cash Flow: GBX 15.09 per share
• Price / Cash Flow: 5.07
• Book Value: GBX 17 per share
• Price / Book: 4.50

Miscellaneous

• Outstanding Shares: 37,760,000
• Free Float: N/A
• Market Cap: £28.89 million
• Optionable: Not Optionable
• Beta: -0.18